版本:
中国

BRIEF-Galectin Therapeutics drug demonstrates clinically significant effect in eczema patients

March 14 Galectin Therapeutics Inc:

* Galectin Therapeutics Inc - GR-MD-02 demonstrates clinically significant effect in patients with severe and refractory atopic dermatitis (eczema)

* Galectin Therapeutics Inc - there were no serious adverse events observed Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐